000			02169 a2200613 4500
005			20250518083949.0
264		0	_c20210210
008			202102s 0 0 eng d
022			_a1556-0961
024	7		_a10.1007/s12028-019-00898-y _2doi
040			_aNLM _beng _cNLM
100	1		_aShin, Samuel S
245	0	0	_aComparison of Traumatic Intracranial Hemorrhage Expansion and Outcomes Among Patients on Direct Oral Anticoagulants Versus Vitamin k Antagonists. _h[electronic resource]
260			_bNeurocritical care _c04 2020
300			_a407-418 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural
650	0	4	_aAccidental Falls
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAnticoagulants _xadverse effects
650	0	4	_aAntifibrinolytic Agents _xtherapeutic use
650	0	4	_aAntithrombins _xadverse effects
650	0	4	_aBlood Coagulation Factors _xtherapeutic use
650	0	4	_aCoagulants _xtherapeutic use
650	0	4	_aDabigatran _xadverse effects
650	0	4	_aDisease Progression
650	0	4	_aFactor Xa Inhibitors _xadverse effects
650	0	4	_aFemale
650	0	4	_aGlasgow Outcome Scale
650	0	4	_aHumans
650	0	4	_aIntracranial Hemorrhage, Traumatic _xchemically induced
650	0	4	_aLength of Stay
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMortality
650	0	4	_aNeurosurgical Procedures
650	0	4	_aPlasma
650	0	4	_aPlatelet Transfusion
650	0	4	_aPyrazoles _xadverse effects
650	0	4	_aPyridines _xadverse effects
650	0	4	_aPyridones _xadverse effects
650	0	4	_aRetrospective Studies
650	0	4	_aRivaroxaban _xadverse effects
650	0	4	_aThiazoles _xadverse effects
650	0	4	_aVitamin K _xtherapeutic use
650	0	4	_aWarfarin _xadverse effects
700	1		_aMarsh, Elisabeth B
700	1		_aAli, Hasan
700	1		_aNyquist, Paul A
700	1		_aHanley, Daniel F
700	1		_aZiai, Wendy C
773	0		_tNeurocritical care _gvol. 32 _gno. 2 _gp. 407-418
856	4	0	_uhttps://doi.org/10.1007/s12028-019-00898-y _zAvailable from publisher's website
999			_c30611536 _d30611536